Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/36242| Title: | Empagliflozin-Induced Changes in Epicardial Fat The Centerpiece for Myocardial Protection? | Authors: | MULLENS, Wilfried MARTENS, Pieter |
Issue Date: | 2021 | Publisher: | ELSEVIER SCI LTD | Source: | JACC-Heart Failure, 9 (8) , p. 590 -593 | Keywords: | CMR;SGLT2-inhibitors;epicardial adipose tissue;heart failure;myocardial fibrosis;Benzhydryl Compounds;Glucosides;Humans;Myocardium;Heart Failure | Document URI: | http://hdl.handle.net/1942/36242 | ISSN: | 2213-1779 | e-ISSN: | 2213-1787 | DOI: | 10.1016/j.jchf.2021.05.006 | ISI #: | 000678493300006 | Rights: | 2021 by the American College of Cardiology Foundation. Published by Elsevier. | Category: | A2 | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Empagliflozin-Induced Changes in Epicardial Fat.pdf | Published version | 714.82 kB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
17
checked on Apr 22, 2024
Page view(s)
56
checked on Jul 22, 2022
Download(s)
4
checked on Jul 22, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.